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COPD = chronic obstructive pulmonary disease; NIV = noninvasive mechanical ventilation; WOB = work of breathing.
Available online http://ccforum.com/content/5/4/179
Human airways are complex tubes, and airflow in a tube
may occur in a laminar, a transitional or a turbulent manner
[1]. Reynolds number can approximately predict the
nature of flow [2]. Flow characteristics are determined by
complex interplays between many different factors, includ-
ing the branching patterns of trachea and bronchi, the
diameter of the conduits, the angles of branching, and the
degree of roughness of the walls. The flow characteristics
in the airways may also vary depending on the inspiratory
and expiratory flow rates [2,3].
During quiet breathing in normal humans, a transition from
turbulent to laminar flow occurs through the trachea to
around the second generation of bronchi. In patients with
airways obstruction, however, turbulent flow occurs very fre-
quently, even in low breathing rates and quiet breathing pat-
terns [4]. This leads to increased work of breathing (WOB).
Breathing helium decreases work of
breathing
In turbulent flows, the pressure necessary to generate a
given flow rate is dependent on the density of the inspired
gases [4,5]. Helium has a density that is significantly lower
than that of air [4]. Therefore, a mixture of helium and
oxygen, termed heliox, has a lower density than does a
mixture of nitrogen and oxygen (air, or airox) [6,7]. Breath-
ing heliox leads to a reduction in resistance to flow within
the airways, and consequently to a decrease in the WOB,
particularly in disorders that are characterized by
increased airways resistance [8]. These beneficial effects
have been observed in a few patients with asthma, chronic
obstructive pulmonary disease (COPD), bronchiolitis,
bronchopulmonary dysplasia and upper airways obstruc-
tion [9]. Heliox has not only been used in patients breath-
ing spontaneously, but also in the settings of both invasive
mechanical ventilation (ie with tracheal intubation) [10]
and noninvasive mechanical ventilation (NIV) [11,12]. Nev-
ertheless, the usefulness of heliox in the intensive care unit
remains debatable.
The controversy regarding the use of heliox
Upper airways obstruction
In upper airways obstruction, heliox appears to be a rea-
sonable option in severe respiratory distress that results
from upper airways obstruction [13]. The gas mixture
may allow the intensivist to ‘buy time’ while awaiting
treatment that is aimed at alleviating the obstruction. Of
course, helium per se has no curative action [9,14], and
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Heliox, a mixture of helium and oxygen, has a density that is less than that of air. Breathing heliox leads
to a reduction in resistance to flow within the airways, and consequently to a decrease in the work of
breathing (WOB), particularly in disorders that are characterized by increased airways resistance.
Beneficial effects have been observed in patients with asthma, chronic obstructive pulmonary disease
(COPD), bronchiolitis, bronchopulmonary dysplasia and upper airways obstruction. Until we have
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complications and high costs.
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in a randomized protocol in children with moderate
upper airways obstruction [15] there was no difference
between heliox and racemic epinephrine (adrenaline) in
alleviating symptoms.
Acute asthma crisis
There is controversy regarding the use of heliox in acute
asthma crisis. In a meta-analysis of four randomized con-
trolled trials performed in children and adults presenting at
the emergency room with moderate to severe asthma
[16], there was no evidence favouring the use of heliox.
However, there are several studies (randomized protocols)
that reported findings in favour of heliox in acute severe
asthma [17–19], showing a more rapid decrease in pulsus
paradoxus and in airflow obstruction with helium than with
air oxygen mixtures in nonintubated patients. As in upper
airways obstruction, there is no curative effect of heliox in
asthma crisis, and in no circumstances should heliox
replace aggressive bronchodilator and corticosteroid
therapy [9].
Our present policy is that, in acute severe asthma in spon-
taneously breathing patients, heliox can be given after
failure of the initial bronchodilator therapy. In so doing we
aim to avoid intubation, which (as reported by many
authors [20,21]) is a dangerous procedure, particularly in
asthmatic persons. Heliox has also been used in intubated
asthma patients, and an improvement in blood gases with
a reduction in inflation pressure was observed [22]. From
a practical standpoint, we usually restrict the use of heliox
to patients who are difficult to ventilate, with high inflation
pressures and haemodynamic instability.
Chronic obstructive pulmonary disease
Heliox has been used in both nonintubated and intubated
COPD patients. NIV has become the standard initial treat-
ment in the majority of such patients [23]. COPD patients
in acute decompensation are at risk for respiratory failure
precipitated by an increase in their WOB, leading to inspi-
ratory muscle fatigue. NIV decreases the WOB in these
patients [24]. Therefore, it was hypothesized that the
WOB associated with NIV could be further reduced by
combining that form of ventilation with heliox. Two studies
have been reported [11,12] that support this hypothesis.
However, the proof that NIV with heliox is superior to NIV
with an air–oxygen mixture in avoiding intubation in COPD
patients is nevertheless lacking. We are aware of two
ongoing multicentre trials in Europe that are attempting to
resolve this issue. Until the results of those studies are
known, it seems wise to refrain from introducing heliox into
routine practice because of the costs of the gas.
Heliox has also been used in COPD patients once intu-
bated and mechanically ventilated, in order to reduce intrin-
sic positive end-expiratory pressure and hyperinflation, and
to lessen the impact of high alveolar pressure on haemody-
namic and respiratory mechanics [25]. By reducing the res-
piratory resistance, heliox could enhance expiratory flow
rate, and it could help to reduce intrinsic positive end-expi-
ratory pressure. This was recently demonstrated in intu-
bated and acutely decompensated COPD patients [10].
Thus, heliox may be administered to mechanically venti-
lated COPD patients with high levels of dynamic hyperinfla-
tion and severe consequences on haemodynamics and
high respiratory pressures. Use of heliox while weaning the
patient from the respirator remains to be investigated.
Other uses
Other more anecdotal uses of heliox have been reported,
including use in children with acute bronchiolitis [26] or
bronchopulmonary dysplasia [27], during bronchoscopy
[28], and even as a treatment for pneumothorax [29] and
hyperammonaemia [30].
Technical and cost issues may discourage
widespread use … for now
Several words should be added regarding the technical
and the financial issues associated with the use of helium.
In spontaneously breathing patients, heliox (generally pres-
surized as 78:22 helium:oxygen) should be administered
with a nonrebreather face mask, and if necessary oxygen
can be added through a nasal canula. The use of heliox
with a ventilator raises various technical and safety issues
(fractional inspiration of oxygen measurements, volume
measurements, valve functioning, etc) that need to be
resolved before we can begin to use this mixture of gas in
ventilated patients [31,32].
Finally, even if helium is the second most abundant
element in the universe, the extraction and processing
costs on Earth are high. In Switzerland, a 60-l tank of
78:22 heliox pressurized at 200 Bars (10,000 l at atmos-
pheric pressure) costs US$275. However, these high
costs should be balanced against the benefits, such as
improving patient outcome and reducing the duration of
intensive care unit stay. Such issues should be addressed
in further studies into heliox therapy.
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